Log in
Enquire now
‌

US Patent 11505611 FGFR3 antibodies and methods of use

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Genzyme
Genzyme
Current Assignee
Genzyme
Genzyme
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11505611
Date of Patent
November 22, 2022
Patent Application Number
17407774
Date Filed
August 20, 2021
Patent Citations
‌
US Patent 10421807 Interleukin-31 monoclonal antibody
‌
US Patent 10000571 Anti-FGFR3 antibodies and methods using same
‌
US Patent 10287356 Anti-FGFR3 antibodies and methods using same
‌
US Patent 10436786 Methods for detecting truncated receptors using antibody-based arrays
Patent Primary Examiner
‌
Marianne P Allen

Anti-FGFR3 antigen-binding proteins and antigen-binding binding fragments thereof are provided. Methods of inhibiting FGFR3 activity and methods of treating FGFR3-mediated diseases and disorders are also provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11505611 FGFR3 antibodies and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.